Themis Medicare Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Low debt relative to equity (D/E 0.3x)
Concerns
- Low capital efficiency (ROCE 2.7%)
- Premium to sector peers (P/E 617x vs industry 54.7x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,899 | ₹4.6L Cr | 36.1 | 5.46 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,100 | ₹2.4L Cr | 81.1 | 14.42 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,857 | ₹1.8L Cr | 82.8 | 19.58 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,650 | ₹1.2L Cr | 59.1 | 13.13 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,385 | ₹1.1L Cr | 31.3 | 3.25 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,120 | ₹1.1L Cr | 23 | 4.16 | 21.2 | 21.1 | 0.38 |
| LAURUSLABS Laurus Labs Limited | ₹1,840 | ₹99K Cr | 90.9 | 18.74 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
THEMISMED · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 67.16% | 67.15% | 67.15% | 67.15% | 67.15% | 67.15% |
| FII | 0.01% | 0.03% | 0.05% | 0.10% | 0.10% | 0.14% |
| DII | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public | 32.82% | 32.81% | 32.79% | 32.74% | 32.75% | 32.70% |
Latest News
All newsThemis Medicare announces board meeting outcomes for Q1FY26.
*Themis Medicare announces board meeting outcomes for Q1FY26.* The company reviewed **consolidated financial results for the period ended June 30, 2026**. No major strategic moves or financial surprises were disclosed. Results are awaited for detailed performance assessment. 📊 *STOCKS:* $THEMIS | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Earnings
Themis Medicare sees spurt in trading volume
*Themis Medicare sees spurt in trading volume* — Themis Medicare Limited witnessed a significant spike in trading volume, prompting the NSE to seek clarification to safeguard investor interests. The company has since submitted its response to the exchange. No major corporate announcement was disclosed, but the surge may indicate heightened investor speculation. 📊 *STOCKS:* THEMIS | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #volume